{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:11:25Z","timestamp":1788610285756,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["WXLH202402034"],"award-info":[{"award-number":["WXLH202402034"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008083","name":"Xihua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC2117"],"award-info":[{"award-number":["2024NSFSC2117"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nano.2026.103011","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:28:46Z","timestamp":1787390926000},"page":"103011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preparation of glycyrrhizic acid functionalized nanostructured lipid carrier loaded with tanshinone IIA and its anti-hepatic fibrosis effect"],"prefix":"10.1016","volume":"76","author":[{"given":"Jijiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nano.2026.103011_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.nano.2026.103011_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.nano.2026.103011_bb0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.nano.2026.103011_bb0020","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.7150\/ijbs.92749","article-title":"Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells","volume":"20","author":"Hao","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"12","key":"10.1016\/j.nano.2026.103011_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123406","article-title":"Maresin-1 prevents liver fibrosis by targeting Nrf2 and NF-\u03baB, reducing oxidative stress and inflammation","volume":"10","author":"Rodr\u00edguez","year":"2021","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.nano.2026.103011_bb0030","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1039\/D1BM01499D","article-title":"Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex","volume":"9","author":"Ren","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.nano.2026.103011_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2026.108337","article-title":"Targeted surface engineered magnetic nanoformulation for hepatocellular carcinoma: a preclinical approach to improve in vivo safety and bioavailability","volume":"121","author":"Sohail","year":"2026","journal-title":"J Drug Delivery Sci Technol"},{"issue":"10","key":"10.1016\/j.nano.2026.103011_bb0040","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/acsbiomaterials.4c00532","article-title":"Tanshinone IIA loaded inhaled polymer nanoparticles alleviate established pulmonary fibrosis","volume":"10","author":"Chen","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.nano.2026.103011_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155620","article-title":"Tanshinone IIA positively regulates the Keap1-Nrf2 system to alleviate pulmonary fibrosis via the sestrin2-sqstm1 signaling axis-mediated autophagy","volume":"129","author":"Wu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2026.103011_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2015.03.002","article-title":"Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles","volume":"73","author":"Meng","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2026.103011_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110547","article-title":"Tanshinone IIA attenuates acetaminophen-induced hepatotoxicity through HOTAIR-Nrf2-MRP2\/4 signaling pathway","volume":"130","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2026.103011_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112689","article-title":"A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis","volume":"253","author":"Shi","year":"2020","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.nano.2026.103011_bb0065","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.4081\/ejh.2025.4218","article-title":"Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling","volume":"69","author":"Wang","year":"2025","journal-title":"Eur J Histochem"},{"issue":"1","key":"10.1016\/j.nano.2026.103011_bb0070","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2022.11413","article-title":"Tanshinone IIA regulates the TGF-\u03b21\/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis","volume":"24","author":"Xu","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.nano.2026.103011_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2016.11.046","article-title":"Tanshinone IIA induced cell death via miR30b-p53-PTPN11\/SHP2 signaling pathway in human hepatocellular carcinoma cells","volume":"796","author":"Ren","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nano.2026.103011_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155585","article-title":"Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-\u03baB pathways","volume":"132","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2026.103011_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2020.02.015","article-title":"Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responses","volume":"150","author":"Lyu","year":"2020","journal-title":"Free Rad Biol Med"},{"issue":"6","key":"10.1016\/j.nano.2026.103011_bb0090","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/biof.1679","article-title":"Nerolidol protects the liver against cyclophosphamide-induced hepatic inflammation, apoptosis, and fibrosis via modulation of Nrf2, NF-\u03baB p65, and caspase-3 signaling molecules in Swiss albino mice","volume":"46","author":"Iqubal","year":"2020","journal-title":"BIOFACTORS"},{"key":"10.1016\/j.nano.2026.103011_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112689","article-title":"A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis","volume":"253","author":"Shi","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.nano.2026.103011_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jep.2016.06.011","article-title":"Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-\u03b21\/Smads signaling pathway modulation","volume":"190","author":"Zhou","year":"2016","journal-title":"J Ethnopharmacol"},{"issue":"17","key":"10.1016\/j.nano.2026.103011_bb0105","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.3748\/wjg.v21.i17.5271","article-title":"Glycyrrhizic acid inhibits apoptosis and fibrosis in carbontetrachloride-induced rat liver injury","volume":"21","author":"Bo Liang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nano.2026.103011_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155878","article-title":"Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2","volume":"133","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2026.103011_bb0115","article-title":"Application of glycyrrhizic acid and glycyrrhetinic acid in the drug delivery system","volume":"97","author":"Zhao","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2026.103011_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.138280","article-title":"The self-assembly of glycyrrhizic acid into nanofibrils","volume":"699","author":"Trindade","year":"2025","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2026.103011_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J Drug Delivery Sci Technol"},{"issue":"4","key":"10.1016\/j.nano.2026.103011_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/03639045.2025.2468811","article-title":"Advancements in nanotechnology for targeted drug delivery in idiopathic pulmonary fibrosis: a focus on solid lipid nanoparticles and nanostructured lipid carriers","volume":"51","author":"K","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2026.103011_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2023.105643","article-title":"The novel hepatoprotective effects of silibinin-loaded nanostructured lipid carriers against diazinon-induced liver injuries in male mice","volume":"197","author":"Salimi-Sabour","year":"2023","journal-title":"Pesticide Biochem Physiol"},{"key":"10.1016\/j.nano.2026.103011_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.foodchem.2017.01.015","article-title":"Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3","volume":"225","author":"Park","year":"2017","journal-title":"Food Chem"},{"key":"10.1016\/j.nano.2026.103011_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.104041","article-title":"Pioglitazone-loaded nanostructured lipid carriers: in-vitro and in-vivo evaluation for improved bioavailability","volume":"79","author":"Faiz","year":"2023","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.nano.2026.103011_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119569","article-title":"Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption","volume":"586","author":"Zhu","year":"2020","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.nano.2026.103011_bb0155","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1007\/s00210-024-03223-3","article-title":"The effect of physical stability and modified gastrointestinal tract behaviour of resveratrol-loaded NLCs encapsulated alginate beads","volume":"397","author":"Manikandan","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.nano.2026.103011_bb0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40199-020-00355-8","article-title":"Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator","volume":"28","author":"Abd El-Halim","year":"2020","journal-title":"DARU J Pharm Sci"},{"key":"10.1016\/j.nano.2026.103011_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.126852","article-title":"Fabrication of oral sustained release capecitabine loaded nanostructured lipid carriers with improved bioavailability and prolonged anticancer effects","volume":"421","author":"Fawad","year":"2025","journal-title":"J Mol Liq"},{"key":"10.1016\/j.nano.2026.103011_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2025.136938","article-title":"Unveiling the potential of nano-structured lipid carriers for oral administration of cefepime: bioavailability and safety investigations","volume":"718","author":"Ghani","year":"2025","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"1","key":"10.1016\/j.nano.2026.103011_bb0175","doi-asserted-by":"crossref","first-page":"23350","DOI":"10.1038\/s41598-025-06926-6","article-title":"Development and evaluation of the rivaroxaban loaded nanostructured lipid carriers for improved oral bioavailability and safety","volume":"15","author":"Alamri","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.103011_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128670","article-title":"Rhamnolipids-based nanostructured lipid carriers: effect of lipid phase on physicochemical properties and stability","volume":"344","author":"Azevedo","year":"2021","journal-title":"Food Chem"},{"key":"10.1016\/j.nano.2026.103011_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2021.106888","article-title":"Synergistic effect of glycyrrhizic acid and cellulose nanocrystals for oil-water interfacial stabilization","volume":"120","author":"Ma","year":"2021","journal-title":"Food Hydrocoll"},{"key":"10.1016\/j.nano.2026.103011_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114376","article-title":"Dual-ligand-functionalized nanostructured lipid carriers as a novel dehydrocavidine delivery system for liver fibrosis therapy","volume":"246","author":"Su","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2026.103011_bb0195","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.2147\/IJN.S331690","article-title":"Modified lipid nanocapsules for targeted Tanshinone IIA delivery in liver fibrosis","volume":"16","author":"Ashour","year":"2021","journal-title":"Int J Nanomed"},{"issue":"6","key":"10.1016\/j.nano.2026.103011_bb0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10717544.2014.898110","article-title":"Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration","volume":"22","author":"Gaba","year":"2014","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.103011_bb0205","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.11.064","article-title":"Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin","volume":"162","author":"Fathi","year":"2018","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2026.103011_bb0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2021.08.016","article-title":"Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles","volume":"338","author":"Keck","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103011_bb0215","article-title":"Nanomedicine for oral delivery: strategies to overcome the biological barriers","volume":"10","author":"Kubiatowicz","year":"2025","journal-title":"Small Methods"},{"issue":"39","key":"10.1016\/j.nano.2026.103011_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202404658","article-title":"The dual-target nanoparticles with ROS sensitivity inhibit the hedgehog signaling pathway and decrease oxidative stress in activated hepatic stellate cells to alleviate liver fibrosis","volume":"34","author":"Zhang","year":"2024","journal-title":"Adv Funct Mater"},{"issue":"5","key":"10.1016\/j.nano.2026.103011_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23050989","article-title":"Effects of UV-B radiation on the content of bioactive components and the antioxidant activity of Prunella vulgaris L. Spica during development","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.nano.2026.103011_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030309","article-title":"DPPH measurements and structure\u2014activity relationship studies on the antioxidant capacity of phenols","volume":"13","author":"Yamauchi","year":"2024","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.nano.2026.103011_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04787","article-title":"Synthesis, antidiabetic, antioxidant and anti-inflammatory activities of novel hydroxytriazenes based on sulpha drugs","volume":"6","author":"Dayma","year":"2020","journal-title":"Heliyon"},{"issue":"47","key":"10.1016\/j.nano.2026.103011_bb0240","doi-asserted-by":"crossref","first-page":"64536","DOI":"10.1021\/acsami.4c14357","article-title":"Target-engineered liposomes decorated with nanozymes alleviate liver fibrosis by remodeling the liver microenvironment","volume":"16","author":"Yang","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.103011_bb0245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.nano.2026.103011_bb0250","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1021\/acsnano.5c00136","article-title":"Vitamin A-integrated cinnamaldehyde nanoemulsion: a nanotherapeutic approach to counteract liver fibrosis via gut\u2013liver axis modulation","volume":"19","author":"Niu","year":"2025","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.nano.2026.103011_bb0255","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hep.32204","article-title":"Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis","volume":"75","author":"Sanyal","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.nano.2026.103011_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125655","article-title":"Surfactant-based drug delivery systems for cancer therapy: advances, challenges, and future perspectives","volume":"679","author":"Nagaraj","year":"2025","journal-title":"Int J Pharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:13:14Z","timestamp":1788606794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S1549963426001127"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103011","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation of glycyrrhizic acid functionalized nanostructured lipid carrier loaded with tanshinone IIA and its anti-hepatic fibrosis effect","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103011"}}